Price (delayed)
$34.665
Market cap
$3.58B
P/E Ratio
13.38
Dividend/share
N/A
EPS
$2.59
Enterprise value
$6.37B
Syneos Health is the only fully integrated biopharmaceutical solutions organization. Our company, including a Contract Research Organization (CRO) and Contract Commercial Organization (CCO), is purpose-built to accelerate customer performance to
There are no recent dividends present for SYNH.
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.